Jazz Pharmaceuticals Unveils New Research at 2025 American Epilepsy Society Meeting Jazz Pharmaceuticals showcased new data on Epidiolex® at the AES 2025 Annual Meeting, emphasizing its impact on treatment-resistant epilepsies.

Jazz Pharmaceuticals Unveils New Research at 2025 American Epilepsy Society Meeting #United_States #Atlanta #Jazz_Pharmaceuticals #Epidiolex #AES_2025